Adult stem cell therapy begins human trial

For the first time in humans a doctor has extracted adult stem cells from fat tissue and injected them directly into the heart as a therapy for angina and heart disease. Physicians in Spain--working with investigators at the Texas Heart Institute in Houston--say that it will be at least six months before they can determine if the therapy is working. Another 35 volunteers suffering from chronic myocardial ischemia, a severe form of end-stage coronary artery disease, will be given the therapy developed by Cytori Therapeutics. In preclinical tests the therapy spurred improved circulation in the heart.

"Patients with chronic heart disease today have few options making this an important milestone for the affected patients and doctors that treat them," said Marc H. Hedrick, M.D., president for Cytori Therapeutics. "This study is designed to show unequivocally whether the cells from our Celution System can be safely introduced into the heart."

- see the release on the trial

Related Articles:
New study to use stem cells after heart attacks. Report
Heart muscle created from embryonic stem cells. Report
Scientists grow new heart valves from stem cells. Report

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.